8-K 1 primedex_8k-100903.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. ____________________________________________________________ FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event report) October 9, 2003 PRIMEDEX HEALTH SYSTEMS, INC. ------------------------------------------------------ [Exact Name or Registrant as specified in its Charter] New York 0-19019 13-3326724 -------- ------- ---------- [State or other jurisdiction [Commission File No.] [IRS Employer of incorporation] Identification No.] 1510 Cotner Avenue, Los Angeles, California 90025-3303 ------------------------------------------------------ [Address of principal executive officers; ZIP Code] Registrant's Telephone No., including Area Code: (310)478-2800 ___________________________________________________________________ Former address, if changed since last report Item 5. Other Events and Regulation FD Disclosure ------- ----------------------------------------- Registrant's Chapter 11 Plan of Reorganization filed with the Bankruptcy Court in Los Angeles, California in connection with Registrant's default in its obligation to redeem the $16.3 million in its outstanding 10% convertible subordinated debentures due June 30, 2003, was confirmed by order of the Court on October 9, 2003. The Court order approved the extension of the debentures for an additional five years through June 30, 2008, in return for which Registrant agreed to (i) increase the annual interest rate to 11.5%; (ii) reduce the conversion rate to $2.50; and (iii) agreed not to redeem the debentures prior to July 1, 2005. The Bankruptcy proceeding had no other impact on Registrant or its operations. SIGNATURES Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: October 9, 2003 PRIMEDEX HEALTH SYSTEMS, INC. By: /S/ Howard G. Berger, M.D. --------------------------------- Howard G. Berger, M.D., President